TITLE
Transriptome analysis of VCAP and CWR22-Pc cell lines after concomittant treatment with androgen with bicalutamide and enzalutamide

ORGANISM
Homo sapiens

SUMMARY
Transriptome analysis of VCAP and CWR22-Pc cell lines after concomittant treatment with androgen with bicalutamide and enzalutamide

DESIGN
VCAP and CWR22-Pc cells growing in log phase were treated for 24 hours with vehicle, the androgen DHT, and DHT plus either bicalutamide or enzalutamide for 24 hours.

PLATFORM
GPL10558 Illumina HumanHT-12 V4.0 expression beadchip

CITATIONS
Has this study been published? Please login to update or notify GEO .

